Sabrina Raizada

Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial

Andrew P. Cope, Marianna Jasenecova, Joana C. Vasconcelos et al. · The Lancet · 2024 · 160 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials

Felice Rivellese, Alessandra Nerviani, Giovanni Giorli et al. · The Lancet Rheumatology · 2023 · 68 citations · Full text

Medicine, Immunology, Pathobiology +15

Spontaneously Resolving Joint Inflammation Is Characterised by Metabolic Agility of Fibroblast-Like Synoviocytes

Jane Falconer, Valentina Pucino, Sally A. Clayton et al. · Frontiers in Immunology · 2021 · 26 citations · Full text

Life Sciences, Biochemistry, Cell Biology +16

The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shielding

Natasha Cleaton, Sabrina Raizada, Nick Barkham et al. · Rheumatology International · 2021 · 14 citations · Full text

Medicine, Health Sciences, Internal Medicine +4

UK–South Asian patients’ experiences of and satisfaction toward receiving information about biologics in rheumatoid arthritis

Kanta Kumar, Sabrina Raizada, Christian Mallen et al. · Patient Preference and Adherence · 2018 · 10 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +13